Biennial International LRRK2 Meeting
A Biochemical Society Scientific Meeting
Leucine Rich Repeat Kinase 2 has emerged as a major genetic determinant of Parkinson’s disease, placing this multidomain enzyme at the core of research efforts for the development of both disease modifying therapies as well as disease related biomarkers. Given the success of the previous LRRK2 focused meetings, we launched a third edition of this event where the latest biochemical, cellular and translational LRRK2 research was discussed in the frame of future clinical applications.
- LRRK2 genetics
- LRRK2 structural biology
- LRRK2 animal models
- LRRK2 in immune function
- LRRK2 intracellular pathways
- LRRK2/alpha-synuclein interaction in Parkinson’s disease pathogenesis
- LRRK2 in neuronal function
- LRRK2 substrate and effectors
- LRRK2 pathways to clinic
- LRRK2 in other diseases
View full programme here.
Abstract deadline: Abstract submission has now closed.
Oral communication slots were available at this meeting. All attendees, particularly researchers in the early stages of their career, are invited to submit a poster abstract for consideration as an oral communication.
Student Bursaries are available for this meeting.
Not a member of the Biochemical Society? Join today and save up to £100 on your registration fee.